A single consultation with a nurse when cancer treatment ends can have a great impact on a patient’s ongoing physical and emotional well-being, according to a new program designed by the Queensland University of Technology School of Nursing and Midwifery.
Participants in a pilot program created to help cancer survivors self-manage their health and emotional concerns have reported a lower need for ongoing information and emotional support, compared with those who did not take part in the program..
A gene, known as an androgen receptor (AR), is found in both prostate and breast cancers and has opposite effects on the two diseases, according to a recent study.
A safer and more efficient treatment system is being developed for lung cancer patients, according to scientists at the University of Strathclyde in Glasgow.
Women with high-grade ovarian cancer involving tumors with BRCA2 mutations live longer and have a better response to platinum-based chemotherapy, researchers at The University of Texas MD Anderson Cancer Center and the Institute for Systems Biology report in the Journal of the American Medical Association.
There is a new biotechnology that may assist with the detection of prostate cancer and the reduction of unnecessary prostate cancer biopsies along with subsequent overtreatment. Due to the discovery of specific prostate cancer DNA fusions, a new urine test for prostate cancer was developed by researchers at the University of Michigan.
Years after treatment, 45% of cancer survivors in Northern Ireland suffer from physical and mental health problems, according to new research from Macmillan Cancer Support and Queen’s University Belfast.
Prostate cancer developed more often in men who took 400 international units (IU) of vitamin E daily compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Updated results appeared October 12, 2011, in the Journal of the American Medical Association.
A combination of chemotherapy and Herceptin significantly increases survival in women with early-stage aggressive breast cancer, according to a study by UCLA’s Jonsson Comprehensive Cancer Center published in the October 6, 2011, edition of the New England Journal of Medicine.
Also, anthracyclines aren’t required to treat early-stage breast cancer successfully, and the associated toxicities can and should be avoided, said study lead author Dennis Slamon, MD, PhD, whose basic laboratory and clinical research led to the development of Herceptin.
According to new research, advanced imaging with positron emission tomography (PET) scans demonstrates great potential to determine which patients with inoperable lung cancer possess more aggressive tumors and require additional treatment beyond standard chemotherapy/radiation therapy.
“We can expect a dramatic increase in the number of older adults who are diagnosed with or carry a history of cancer,” said Julia Rowland, PhD, director of the Office of Cancer Survivorship in the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI). “Cancer is largely a disease of aging, so we’re seeing yet another effect of the baby boom generation and we need to prepare for this increase.”
To sign up for our newsletter or print publications, please enter your contact information below.
